Class II Recall: Medline Syringes, 38,230 Units, 510(k) Clearances Rescinded
Summary
FDA classified a Class II device recall for Medline Industries LP syringes after the firm's 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing were rescinded due to no marketing application. The recall covers 38,230 units across 26 lot numbers distributed nationwide. Consignees must quarantine affected product, complete a response form, and notify downstream customers if they distributed the product.
What changed
FDA issued a Class II recall classification for Medline Industries LP angiographic syringes after determining that 510(k) clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing had been rescinded due to absence of a valid marketing application. The recall encompasses 26 lot numbers across 10 product models totaling 38,230 units distributed nationwide.
Healthcare facilities and distributors that received these syringes must immediately quarantine affected inventory and submit a response form to Medline. Distributors who further sold or transferred the product are obligated under FDA regulations to notify their own customers of the recall. Over-labels and instructions for affected inventory will be provided by Medline upon receipt of the completed response form.
What to do next
- Immediately check your stock for the affected item number(s) and lot number(s) listed in the recall portal. Quarantine all affected product.
- Complete your response form. List the quantity of affected product you have in inventory on the form. Even if you do not have any affected product, submit the form to Website link: https://recalls.medline.com
- If you are a distributor or have resold or transferred this product to another company or individual, you are required by FDA regulations to notify them of this recall communication.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Class 2 Device Recall Medline Syringes
- Databases
| 510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards |
| CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | |
| New Search | ) |
| | Class 2 Device Recall Medline Syringes | |
| Date Initiated by Firm | February 25, 2026 |
|---|---|
| Date Posted | April 17, 2026 |
| Recall Status | Open , Classified |
| Recall Number | Z-1831-2026 |
| Recall Event ID | 98599 |
| Product Classification | Injector and syringe, angiographic - Product Code DXT |
| Product | Medline Syringes: |
1) SYRINGE 12ML CONTROL W/ROTATOR, Model Number: DYNJSYR12CWR;
2) SYRINGE 10ML CONTROL W/ROTATOR, Model Number: DYNJSYR10CWR;
3) SYR CONTROL PAD 12ML L/L, Model Number: DYNJSYR12CP;
4) TBG PRESS 72IN M/F ROT BRAID, Model Number: DYNJBRT72R;
5) SYRINGE 10ML CONTROL MLL, Model Number: DYNJSYR10C;
6) SYRINGE 8ML CONTROL MLL, Model Number: DYNJSYR8C;
7) SYRINGE 12ML CONTROL MLL, Model Number: DYNJSYR12C;
8) SYR CONTROL PAD 10ML L/L ROT, Model Number: DYNJSYR10CRP;
9) SYR CONTROL PAD 12ML L/L ROT, Model Number: DYNJSYR12CRP;
10) CTRL SYRINGE 6ML RING ROT L/L, Model Number: DYNJSYRC6CWR |
| Code Information | 1) DYNJSYR12CWR, UDI-DI: 10884389676486(each), 40884389676487(case), Lot Number: 25ABF227;
2) DYNJSYR12CWR, UDI-DI: 10884389676486(each), 40884389676487(case), Lot Number: 25CBC537;
3) DYNJSYR12CWR, UDI-DI: 10884389676486(each), 40884389676487(case), Lot Number: 25EBK855;
4) DYNJSYR12CWR, UDI-DI: 10884389676486(each), 40884389676487(case), Lot Number: 25IDA120;
5) DYNJSYR12CWR, UDI-DI: 10884389676486(each), 40884389676487(case), Lot Number: 25IDA552;
6) DYNJSYR12CWR, UDI-DI: 10884389676486(each), 40884389676487(case), Lot Number: 25IDA648;
7) DYNJSYR12CWR, UDI-DI: 10884389676486(each), 40884389676487(case), Lot Number: 25IDB507;
8) DYNJSYR10CWR, UDI-DI: 10884389672723(each), 40884389672724(case), Lot Number: 25EBH091;
9) DYNJSYR10CWR, UDI-DI: 10884389672723(each), 40884389672724(case), Lot Number: 25EBO178;
10) DYNJSYR10CWR, UDI-DI: 10884389672723(each), 40884389672724(case), Lot Number: 25IDA686;
11) DYNJSYR10CWR, UDI-DI: 10884389672723(each), 40884389672724(case), Lot Number: 25JDA207;
12) DYNJSYR10CWR, UDI-DI: 10884389672723(each), 40884389672724(case), Lot Number: 25JDB599;
13) DYNJSYR12CP, UDI-DI: 10888277236615(each), 40888277236616(case), Lot Number: 25GBD528;
14) DYNJSYR12CP, UDI-DI: 10888277236615(each), 40888277236616(case), Lot Number: 25JDB601;
15) DYNJBRT72R, UDI-DI: 10884389854211(each), 40884389854212(case), Lot Number: 25GBN402;
16) DYNJSYR10C, UDI-DI: 10884389676462(each), 40884389676463(case), Lot Number: 25GBS345;
17) DYNJSYR10C, UDI-DI: 10884389676462(each), 40884389676463(case), Lot Number: 25GBS857;
18) DYNJSYR10C, UDI-DI: 10884389676462(each), 40884389676463(case), Lot Number: 25GBU045;
19) DYNJSYR10C, UDI-DI: 10884389676462(each), 40884389676463(case), Lot Number: 25GBV139;
20) DYNJSYR8C, UDI-DI: 10884389676493(each), 40884389676494(case), Lot Number: 25IDB505;
21) DYNJSYR12C, UDI-DI: 10884389676479(each), 40884389676470(case), Lot Number: 25IDB506;
22) DYNJSYR12C, UDI-DI: 10884389676479(each), 40884389676470(case), Lot Number: 25JDA208;
23) DYNJSYR12C, UDI-DI: 10884389676479(each), 40884389676470(case), Lot Number: 25JDB827;
24) DYNJSYR10CRP, UDI-DI: 10888277236585(each), 40888277236586(case), Lot Number: 25JDA594;
25) DYNJSYR12CRP, UDI-DI: 10888277236592(each), 40888277236593(case), Lot Number: 25JDB600;
26) DYNJSYRC6CWR, UDI-DI: 10889942885732(each), 40889942885733(case), Lot Number: 25JDB602 |
| FEI Number | 1417592 |
| Recalling Firm/
Manufacturer | Medline Industries, LP
3 Lakes Dr
Northfield IL 60093-2753 |
| For Additional Information Contact | Haley Barclay
866-359-1704 |
| Manufacturer Reason
for Recall | The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded. |
| FDA Determined
Cause | No Marketing Application |
| Action | An URGENT MEDICAL DEVICE RECALL dated 2/25/26 was sent to customers.
REQUIRED ACTION:
1. Immediately check your stock for the affected item number(s) and lot number(s) listed in the recall portal. Quarantine all affected product.
2. Complete your response form. List the quantity of affected product you have in inventory on the form. Even if you do not have any affected product, submit the form to
Website link: https://recalls.medline.com Recall Reference #: R-26-020-FGX1
Recall Code: 3. When we receive your response form, we will send over-labels via FedEx overnight to place on affected inventory, with instructions for your staff to remove and discard the affected component prior to using the kit.
4. If you are a distributor or have resold or transferred this product to another company or individual, you are required by FDA regulations to notify them of this recall communication. Include your customers quantities on your response form. When we receive your response form, we will send over-labels to provide to your customers.
Any questions? Contact the Recall Department at 866-359-1704 or recalls@medline.com.
*** An Urgent Medical Device Recall notification letter dated 3/2/26 was sent to customers.
This is a follow-up to a Medline notification you may have received on February 25, 2026. New item numbers and lot numbers have been included with this communication. Recipients receiving this notification for the first time were not affected by the original notification.
REQUIRED ACTIONS:
same as for 2/25/26 letter |
| Quantity in Commerce | 38,230 units |
| Distribution | US Nationwide distribution. |
| Total Product Life Cycle | TPLC Device Report |
| 1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes. | |
Parties
Related changes
Get daily alerts for FDA Device Recalls (Class II)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from FDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when FDA Device Recalls (Class II) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.